BSG IBD Guideline - De-escalation of Therapy

November 14, 2025 • 01:05:43
BSG IBD Guideline - De-escalation of Therapy
BSG From Top to Bottom
BSG IBD Guideline - De-escalation of Therapy

Nov 14 2025 | 01:05:43

/

Show Notes

Part two of seven: Dr. Shahida Din, Chair of our IBD Committee, and Dr. Jonathan Blackwell—both Consultant Gastroenterologists at the Edinburgh IBD Unit—are joined by Mrs. Fiona Rees, Consultant Pharmacist at University Hospitals Sussex, to explore the BSG IBD Guidelines with a focus on therapy de-escalation. Together, they discuss how best to manage patient expectations around treatment and outcomes.

They also take a detailed look at the role of Mesalazine, routes of administration, Thiopurines, anti-TNF therapies, Pulse Therapy, and the importance of continually reassessing treatment plans.

Other Episodes

Episode

September 29, 2026 • 00:09:48
Episode Cover

Impact of Anti-obesity Drugs on Gastric Motility and Implications for the Management of Dyspepsia

In this episode, Dr. Asma Fikree, Consultant Neurogastroenterologist at UCLH and Chair of the BSG Neurogastroenterology & Motility Section and Dr Maria Eugenicos, Senior...

Listen

Episode

August 08, 2025 • 00:25:23
Episode Cover

BSG Sedation Guidelines in Gastrointestinal Endoscopy

Prof. Reena Sidhu, Consultant Gastroenterologist and Honorary Professor at the University of Sheffield, joins Dr. Jabed Ahmed, Gastroenterology Clinical Research Fellow at Imperial College...

Listen

Episode

June 12, 2026 • 00:47:58
Episode Cover

BSG IBD & Pregnancy

In this BSG Podcast episode, Consultant Pharmacist, Fiona Rees is joined by Gastroenterology Registrar, Dr Krishna Shah and Consultant Obstetrician & Gynaecologist, Dr Mandeep...

Listen